SomnoMed Limited
(ASX:SOM) Executive Chairman and CEO Dr Peter Neustadt presents at the ASX Investor Series in Sydney.
The company is focussed on the design, manufacture and commercialisation of oral devices for sleep related disorders.
Mr Neustadt provides a financial snapshot of the company, discusses obstructive sleep apnea and outlines how SomnoMed is positioned for long term growth.
